QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of new products to further enhance…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Apr 24
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of new products to further enhance…
10 Apr 24
Educational sessions explore solving analytical challenges with innovative products
08 Apr 24
QIAGEN today announced the launch of the Investigator Quantiplex Pro FLX Kit, which offers forensic laboratories highest sensitivity…
28 Mar 24
Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology company,…
27 Mar 24
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the release of the QIAstat-Dx Analyzer 2.0, including the…
12 Mar 24
Vetter committed to strengthening Germany as a research and production location
27 Feb 24
As part of the Cancer Moonshot initiative announced at the White House, noul is delighted to announce its…
15 Feb 24
Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with…
08 Feb 24
JEB Technologies, an established leader in end-to-end medical device design and manufacturing, and Medovate Ltd, an award-winning medical…
06 Feb 24
New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs